Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Oligosaccharide Assembly

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...

Proteoglycans

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...

Glycocalyx and its Functions

Glycocalyx and its Functions

The glycocalyx is a carbohydrate-rich, fuzzy-appearing layer on the outer surface of the cell membrane. It is highly hydrophilic, because of this it attracts large amounts of water to the cell's surface. This aids the cell's interaction with the watery environment and also helps it to obtain substances dissolved in the water. It is also important for cell identification, self/non-self determination, and embryonic development and is used in cell-to-cell attachments to form tissues.
Components of...

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

Protein Glycosylation

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...

Matrix Proteoglycans and Glycoproteins

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Homeostatic Plasticity Enables Stable yet Tunable Neuronal Assemblies.

bioRxiv : the preprint server for biology·2026

Same author

BRCA1/2 Reversion Mutations and Cancer Therapy Resistance.

Biology·2026

Same author

Use of UDP-glucose 4-epimerase all4713 from Nostoc sp. PCC 7120 in the synthesis of galactose.

Archives of biochemistry and biophysics·2026

Same author

Zinc-based metal orchestrates early osteoimmune microenvironment to promote angiogenesis via macrophage-derived extracellular vesicles.

Biomaterials·2026

Same author

Structural elucidation and distribution pattern of glucuronic acid in β-glucan from Hypsizygus marmoreus using glycosidase hydrolysis.

Carbohydrate polymers·2026

Same author

NRIP1 disrupts ERα signal in Sjögren's disease via AQP5 suppression and MYC-driven salivary dysfunction.

Experimental & molecular medicine·2026

Search research articles

Related Experiment Video

Updated: May 26, 2026

Rapid Glyco-Qualitative Assessment of Recombinant Proteins Using a Fully Automated System

Rapid Glyco-Qualitative Assessment of Recombinant Proteins Using a Fully Automated System

Published on: June 28, 2024

Structural features for α-galactomannan binding to galectin-1.

Michelle C Miller¹, Anatole A Klyosov, Kevin H Mayo

¹Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota Health Sciences Center, 6-155 Jackson Hall, 321 Church Street, Minneapolis, MN 55455, USA.

|December 14, 2011

Summary

This summary is machine-generated.

Researchers identified the optimal structure for galactomannans (GMs) binding to galectin-1 (gal-1). This involves specific galactose arrangements on mannan chains, aiding in developing GM-based therapeutics.

More Related Videos

Bioinformatics Resources for the Study of Glycan-Mediated Protein Interactions

Bioinformatics Resources for the Study of Glycan-Mediated Protein Interactions

Published on: January 20, 2022

Disentangling Glycan-Protein Interactions: Nuclear Magnetic Resonance (NMR) to the Rescue

Disentangling Glycan-Protein Interactions: Nuclear Magnetic Resonance (NMR) to the Rescue

Published on: May 17, 2024

Related Experiment Videos

Last Updated: May 26, 2026

Rapid Glyco-Qualitative Assessment of Recombinant Proteins Using a Fully Automated System

Rapid Glyco-Qualitative Assessment of Recombinant Proteins Using a Fully Automated System

Published on: June 28, 2024

Bioinformatics Resources for the Study of Glycan-Mediated Protein Interactions

Bioinformatics Resources for the Study of Glycan-Mediated Protein Interactions

Published on: January 20, 2022

Disentangling Glycan-Protein Interactions: Nuclear Magnetic Resonance (NMR) to the Rescue

Disentangling Glycan-Protein Interactions: Nuclear Magnetic Resonance (NMR) to the Rescue

Published on: May 17, 2024

Area of Science:

Biochemistry
Glycobiology
Molecular Biology

Background:

Galectins, particularly galectin-1 (gal-1), bind to galactose-containing carbohydrates.
Previous work showed gal-1 binds a large α-galactomannan (Davanat) at an alternative site.
Understanding specific binding requirements is crucial for therapeutic development.

Purpose of the Study:

To determine the optimal structural signature of α-galactomannans (GMs) for binding to galectin-1 (gal-1).
To elucidate the binding interactions of GMs with gal-1, including both canonical and alternative sites.

Main Methods:

Utilized a series of α-galactomannans (GMs) with varying mannose-to-galactose ratios.
Employed heteronuclear single-quantum coherence nuclear magnetic resonance (HSQC NMR) spectroscopy with (15)N-labeled gal-1.
Applied statistical modeling to analyze binding data.

Main Results:

The optimal GM structure for gal-1 binding features α-D-galactopyranosyl doublets.
These galactose structures are optimally surrounded by at least four mannose residues.
GMs bind to a conserved surface on gal-1, encompassing the alternative Davanat site and parts of the canonical site.

Conclusions:

Defined the specific structural requirements for GM binding to gal-1.
Provided insights into gal-1 interactions with complex polysaccharides.
Findings support the development of galactomannan-based therapeutics for clinical applications.